624 related articles for article (PubMed ID: 19673081)
1. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS
Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
4. Brown spiders and loxoscelism.
da Silva PH; da Silveira RB; Appel MH; Mangili OC; Gremski W; Veiga SS
Toxicon; 2004 Dec; 44(7):693-709. PubMed ID: 15500846
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of antivenom in loxoscelism treatment.
Pauli I; Puka J; Gubert IC; Minozzo JC
Toxicon; 2006 Aug; 48(2):123-37. PubMed ID: 16808942
[TBL] [Abstract][Full Text] [Related]
6. [Total upper lip necrosis and loxoscelism caused by violin spider bite].
Bogdán S; Barabás J; Zacher G; Huszár T; Velich N; Szabó G; Németh Z
Orv Hetil; 2005 Nov; 146(45):2317-21. PubMed ID: 16304811
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
[TBL] [Abstract][Full Text] [Related]
8. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
[TBL] [Abstract][Full Text] [Related]
9. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
[TBL] [Abstract][Full Text] [Related]
10. Proteome analysis of brown spider venom: identification of loxnecrogin isoforms in Loxosceles gaucho venom.
Machado LF; Laugesen S; Botelho ED; Ricart CA; Fontes W; Barbaro KC; Roepstorff P; Sousa MV
Proteomics; 2005 May; 5(8):2167-76. PubMed ID: 15852345
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
[TBL] [Abstract][Full Text] [Related]
12. Brown spider envenomation.
Peterson ME
Clin Tech Small Anim Pract; 2006 Nov; 21(4):191-3. PubMed ID: 17265904
[TBL] [Abstract][Full Text] [Related]
13. Tetracycline and penicillin resistant Clostridium perfringens isolated from the fangs and venom glands of Loxosceles laeta: its implications in loxoscelism treatment.
Catalán A; Espoz MC; Cortés W; Sagua H; González J; Araya JE
Toxicon; 2010 Nov; 56(6):890-6. PubMed ID: 20600224
[TBL] [Abstract][Full Text] [Related]
14. Brown recluse spider envenomation: dermatologic application of hyperbaric oxygen therapy.
Tutrone WD; Green KM; Norris T; Weinberg JM; Clarke D
J Drugs Dermatol; 2005; 4(4):424-8. PubMed ID: 16004015
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
[TBL] [Abstract][Full Text] [Related]
16. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators generated at the site of inoculation of Loxosceles gaucho spider venom.
Barbaro KC; Lira MS; Araújo CA; Pareja-Santos A; Távora BC; Prezotto-Neto JP; Kimura LF; Lima C; Lopes-Ferreira M; Santoro ML
Toxicon; 2010 Nov; 56(6):972-9. PubMed ID: 20615425
[TBL] [Abstract][Full Text] [Related]
18. Biotechnological applications of brown spider (Loxosceles genus) venom toxins.
Senff-Ribeiro A; Henrique da Silva P; Chaim OM; Gremski LH; Paludo KS; Bertoni da Silveira R; Gremski W; Mangili OC; Veiga SS
Biotechnol Adv; 2008; 26(3):210-8. PubMed ID: 18207690
[TBL] [Abstract][Full Text] [Related]
19. A controlled trial of topical nitroglycerin in a New Zealand white rabbit model of brown recluse spider envenomation.
Lowry BP; Bradfield JF; Carroll RG; Brewer K; Meggs WJ
Ann Emerg Med; 2001 Feb; 37(2):161-5. PubMed ID: 11174233
[TBL] [Abstract][Full Text] [Related]
20. Brown spider dermonecrotic toxin directly induces nephrotoxicity.
Chaim OM; Sade YB; da Silveira RB; Toma L; Kalapothakis E; Chávez-Olórtegui C; Mangili OC; Gremski W; von Dietrich CP; Nader HB; Sanches Veiga S
Toxicol Appl Pharmacol; 2006 Feb; 211(1):64-77. PubMed ID: 16005484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
